Aros Pharma APS
Records under this name other than patents Aros Pharma APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Aros Pharma APS
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,718,641 | Pyrrolo [3,4-H] isoquinoline compounds and methods for modulating gated ion channels Lapsed on the fee record Ended May 18, 2018 · USPTO record | Lapsed on the fee record | Ended May 18, 2018 | USPTO record |
| US 6,727,260 | Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders Lapsed on the fee record Ended Apr 27, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 27, 2016 | USPTO record |
| US 7,288,653 | Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders Lapsed on the fee record Ended Oct 30, 2015 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2015 | USPTO record |